Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT05969561
CompletedNCT05969561ClinicalTrials.gov record

Emergency Physician-performed Ultrasound-guided Femoral Nerve Blocks in Patients With Hip Fractures.

Hip Fractures

THE QUICK READ

What this study involves

The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.

Study type
Interventional
Phase
Not applicable
Age range
20 years - Not specified
Sex eligible
All sexes
Healthy volunteers
Not accepted
Participants
72 Actual

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

In this prospective study, emergency physicians perform ultrasound-guided femoral nerve block for patients with hip fractures. We compare the effectiveness of analgesia and patient satisfaction of ultrasound-guided femoral nerve block with liberal use of the pain medicine in the emergency department. The primary outcome is the change in movement-evoked pain score from baseline to 30 minutes. The secondary outcome is patient satisfaction and adverse effects for different method of pain control.

Read the full description

The aim of this study is to compare the effectiveness of ultrasound-guided femoral nerve blocks performed by emergency physicians for pain control in the emergency department with traditional pain medicine.

This study is a prospective before-and-after design. The enrollees are 20-year-old and older adult patients with hip fractures. We use numerical rating scale using a 0-10 scale to assess pain severity at the different time frame after giving pain medicine. The scale zero means "no pain" and scale 10 means "the worst pain imaginable".

The primary outcome is assessed by the reduction of pain scale which are taken on a numeric rating scale every 30 minutes before and after pain management. The secondary outcome compares complications, adverse effects and patient satisfaction for different method of pain control.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

  • Patients older than 20-year-old with hip fractures
  • Stay in the emergency department for at lease two hours

Exclusion Criteria:

  • hemodynamic unstable
  • major trauma in addition to hip fractures
  • the use of any pain management before the arrival of emergency department
  • inability to understood the numerical rating scale after instruction
  • allergy to local anesthetics
  • coagulopathy
  • injection site infection
Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Not randomized
Masking
No masking
Ultrasound-guided femoral nerve block

Patients with hip fractures had underwent Ultrasound-guided femoral nerve block performed by emergency physicians.

Procedure: ultrasound-guided femoral nerve block

The liberal use of pain medication

Patients with hip fractures had given intravenous or intramuscular opioids or NSAID at the emergency department.

Drug: Intravenous or intramuscular pain medication

ultrasound-guided femoral nerve block PROCEDURE

The local analgesia is injected and infiltrated around the femoral nerve under ultrasound guidance.

Intravenous or intramuscular pain medication DRUG

Intravenous or intramuscular pain medication is given for patients with hip fracture.

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Change in movement-evoked pain score from baseline to 30 minutes

Time frame: Baseline and 30 minutes after analgesia

Pain during movement of the affected leg is rated on an 11-point numerical rating scale (NRS; 0 = no pain, 10 = worst pain imaginable) before analgesia (baseline) and 30 minutes after analgesia. The change from baseline is compared between the femoral nerve block group and the intravenous or intramuscular pain medication group.

Secondary measures

Adverse effects

Time frame: two hours

Any adverse effects of different pain medication

Patient satisfaction

Time frame: two hours

The difference of patient satisfaction between ultrasound-guided femoral nerve block and the liberal use of pain medication

Complications of ultrasound-guided femoral nerve block

Time frame: two hours and one week after ultrasound-guided femoral nerve block or after hospital discharge

Any complications of ultrasound-guided femoral nerve block

Change in pain score at rest and with movement

Time frame: Baseline and 30, 60, and 120 minutes after analgesia

Pain at rest and during movement of the affected leg is rated on an 11-point numerical rating scale (NRS; 0 = no pain, 10 = worst pain imaginable). The change from baseline at each time point is compared between groups.

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

NTUH Yunlin BranchDouliu, Yunlin County, TaiwanStatus unknown

Study team and timeline

Lead sponsor
National Taiwan University Hospital
Study start
Jul 3, 2023 Actual
Primary completion
Mar 5, 2025 Actual
Study completion
Dec 30, 2025 Actual
First posted
Aug 1, 2023 Actual
Last updated
Nov 10, 2026 Actual

Official study contacts

No central contact is listed. Check the locations and the official record.

Official study title

Ultrasound-Guided Femoral Nerve Block

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026